PubRank

American Society of Clinical Oncology

Author PubWeight™ 252.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2006 25.12
2 American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007 14.29
3 Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol 2013 12.57
4 American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006 11.07
5 American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005 8.56
6 Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2011 7.24
7 American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 2009 6.77
8 American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2003 6.66
9 American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 2010 6.39
10 American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003 5.69
11 American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007 5.36
12 American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 2009 4.95
13 American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 2010 4.93
14 American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol 2011 4.64
15 American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 2006 4.61
16 Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2012 4.42
17 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med 2010 4.38
18 Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005 4.10
19 Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013 3.92
20 Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2007 3.91
21 Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol 2007 3.85
22 American Society Of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards. J Clin Oncol 2009 3.73
23 American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003 3.71
24 American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol 2009 3.51
25 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol 2000 3.38
26 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. J Clin Oncol 2011 3.21
27 American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol 2014 3.07
28 Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001 3.06
29 Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol 2007 2.93
30 The state of cancer care in america, 2015: a report by the american society of clinical oncology. J Oncol Pract 2015 2.90
31 Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2012 2.62
32 Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2014 2.57
33 Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. Arch Pathol Lab Med 2013 2.54
34 American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer. J Clin Oncol 2011 2.51
35 Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol 2005 2.47
36 Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol 2013 2.43
37 Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001 2.33
38 American Society of Clinical Oncology: Policy for relationships with companies. J Clin Oncol 2013 2.18
39 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol 2010 2.16
40 Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancer. J Clin Oncol 2012 2.15
41 American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol 2010 2.14
42 American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol 2007 2.09
43 Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol 2012 2.02
44 A shortage of oncologists? The American Society of Clinical Oncology workforce study. J Clin Oncol 2007 1.89
45 Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2015 1.77
46 American Society of Clinical Oncology clinical practice guidelines: opportunities and challenges. J Clin Oncol 2008 1.75
47 Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol 2014 1.72
48 American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays. J Clin Oncol 2011 1.71
49 Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol 2008 1.69
50 Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol 2006 1.64
51 The state of cancer care in America, 2014: a report by the American Society of Clinical Oncology. J Oncol Pract 2014 1.64
52 Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2014 1.61
53 Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. Ann Surg Oncol 2012 1.56
54 Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol 2014 1.46
55 American Society of Clinical Oncology policy statement update: tobacco control--reducing cancer incidence and saving lives. 2003. J Clin Oncol 2003 1.45
56 Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome. J Clin Oncol 2007 1.45
57 American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol 2004 1.44
58 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 2000 1.43
59 American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer. J Clin Oncol 2007 1.41
60 Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol 2014 1.40
61 Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2016 1.33
62 American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment. J Clin Oncol 2008 1.29
63 Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol 2007 1.28
64 Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol 2014 1.26
65 ACCO: ASCO core curriculum outline. J Clin Oncol 2005 1.20
66 Antiemetics: American Society of Clinical Oncology Focused Guideline Update. J Clin Oncol 2015 1.20
67 Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. J Clin Oncol 2015 1.15
68 American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards. Oncol Nurs Forum 2009 1.10
69 American Society of Clinical Oncology policy statement: oversight of clinical research. J Clin Oncol 2003 1.09
70 American Society of Clinical Oncology: revised conflict of interest policy. J Clin Oncol 2003 1.07
71 Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood 2002 1.02
72 Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations. J Clin Oncol 2003 1.00
73 Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines. Semin Hematol 2007 0.95
74 Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement. J Clin Oncol 2015 0.92
75 The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology. J Oncol Pract 2016 0.91
76 The American Society of Clinical Oncology Recommended Breast Cancer Surveillance Guidelines can be done in a routine office visit. J Clin Oncol 2005 0.91
77 Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Oncol Pract 2015 0.89
78 American Society Of Clinical Oncology: revised conflict of interest policy. J Clin Oncol 2005 0.88
79 Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy. Oncologist 2011 0.85
80 Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines. Thromb Res 2010 0.85
81 Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology. J Oncol Pract 2014 0.83
82 Potential approaches to sustainable, long-lasting payment reform in oncology. J Oncol Pract 2014 0.83
83 Revisions of and clarifications to the ASCO conflict of interest policy. J Clin Oncol 2005 0.81
84 American Society of Clinical Oncology: background for update of conflict of interest policy. J Clin Oncol 2003 0.81
85 American Society of Clinical Oncology policy for relationships with companies: background and rationale. J Clin Oncol 2013 0.79
86 Prostate cancer survivorship care guidelines: American Society of Clinical Oncology practice guideline endorsement. J Oncol Pract 2015 0.79
87 The 2004 Perugia Antiemetic Consensus Guideline process: methods, procedures, and participants. Support Care Cancer 2004 0.79
88 Criteria for facilities and personnel for the administration of parenteral systemic antineoplastic therapy. Adopted on March 3, 2004 by the American Society of Clinical Oncology. J Clin Oncol 2004 0.78
89 Hereditary colorectal cancer syndromes: American Society of Clinical Oncology clinical practice guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology clinical practice guidelines. J Oncol Pract 2015 0.77
90 Expert opinion 2011 on the use of new anti-resorptive agents in the prevention of skeletal-related events in metastatic bone disease. Wien Klin Wochenschr 2013 0.76
91 American Society of Clinical Oncology Position Statement on Addressing the Affordability of Cancer Drugs. J Oncol Pract 2017 0.75
92 Policy Statement on Site-Neutral Payments in Oncology. J Clin Oncol 2015 0.75
93 Advances in breast oncology: the 2002 ASCO meeting. Curr Med Res Opin 2002 0.75
94 Five things physicians and patients should question. J Okla State Med Assoc 2013 0.75
95 [Epoetin in cancer patients. Guidelines of the ASCO and the ASH for evidence-based clinical practice]. Tumori 2003 0.75
96 Interactions with the investment industry: practical and ethical implications. J Clin Oncol 2007 0.75
97 The State of Cancer Care in America, 2017: A Report by the American Society of Clinical Oncology. J Oncol Pract 2017 0.75
98 [ASCO-Update 2005--Highlights of the 41st Meeting of the American Society of Clinical Oncology/ASCO 2005]. Z Gastroenterol 2005 0.75
99 American Society of Clinical Oncology Statement on the Impact of Utilization Management Policies for Cancer Drug Therapies. J Oncol Pract 2017 0.75
100 American Society of Clinical Oncology statement regarding the use of outside services to prepare or administer chemotherapy drugs. J Clin Oncol 2003 0.75
101 Highlights From: the 2006 American Society of Clinical Oncology Gastrointestinal Cancers Symposium San Francisco, CA, January 2006. Clin Colorectal Cancer 2006 0.75